Koninklijke Philips (PHG) Cash from Financing Activities (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Cash from Financing Activities of -$1.4 billion for Q2 2026, down 321.36% year-over-year from $618.0 million in Q2 2025, and down 4980.75% quarter-over-quarter from -$26.9 million in Q1 2026.
Koninklijke Philips (PHG) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$1.4 billion for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 321.36% year-over-year to -$1.4 billion; the TTM figure through Jun 2026 stood at -$1.3 billion (down 267.03% YoY), while the FY2025 annual figure was $124.6 million, up 123.5% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$1.4 billion, down from -$26.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $618.0 million in Q2 2025, with the low at -$1.4 billion in Q2 2026.
- The 5-year median for Cash from Financing Activities is -$133.6 million (2024), against an average of -$150.9 million.
- The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities jumped 378.44% in 2024, then plunged 321.36% in 2026.
- Koninklijke Philips' Cash from Financing Activities stood at $372.4 million in 2022, then slumped by 345.0% to -$912.4 million in 2023, then jumped by 36.87% to -$576.0 million in 2024, then jumped by 34.92% to -$374.8 million in 2025, then slumped by 265.0% to -$1.4 billion in 2026.
- Business Quant data shows PHG's Cash from Financing Activities at -$1.4 billion in Q2 2026, -$26.9 million in Q1 2026, and -$374.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | -271.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.37 Bn |
| Jun 30, 2026 | -1.37 Bn |
| Mar 31, 2026 | -26.93 Mn |
| Mar 31, 2026 | -26.93 Mn |
| Dec 31, 2025 | -374.82 Mn |
| Dec 31, 2025 | -374.82 Mn |
| Sep 30, 2025 | 501.52 Mn |
| Sep 30, 2025 | 501.52 Mn |
| Jun 30, 2025 | 618.05 Mn |
| Jun 30, 2025 | 618.05 Mn |
| Mar 31, 2025 | -50.49 Mn |
| Mar 31, 2025 | -50.49 Mn |
| Dec 31, 2024 | -575.97 Mn |
| Dec 31, 2024 | -575.97 Mn |
| Sep 30, 2024 | -337.15 Mn |
| Sep 30, 2024 | -337.15 Mn |
| Jun 30, 2024 | 509.37 Mn |
| Jun 30, 2024 | 509.37 Mn |
| Mar 31, 2024 | -133.62 Mn |
| Mar 31, 2024 | -133.62 Mn |